«The STARRS-GM project uses LungHealth software to work through the Standardised Asthma Review and Reduction in SABA (short acting beta agonist) model. It hopes to improve the outcomes for asthmatic patients through proactive identification and reviews for high-risk patients to optimise their management of the condition.»

«AI is being increasingly used within healthcare settings, with its use in diagnostics as the most common application. LungHealth focuses on high-quality, consistent and artificial intelligence-guided asthma consultations. As well as helping high-risk patients in Manchester, it will also provide education and knowledge to both patients and healthcare professionals. The pilot will also support streamlined referrals to specialist services.»

«Eddie McKnight, managing director at National Services for Health Improvement (NSHI), explained: “(the project) will provide participating practices with LungHealth decision support asthma software that will ensure that adult patients receive a complete and thorough asthma review, regardless of the experience of the reviewing clinician, with onward referral to specialist services if required. Patients will also be provided with a personal asthma action plan to help improve their concordance with treatment.»

«“We firmly believe that by pro-actively targeting ‘high-risk patients’ and offering reviews that asthma outcomes in Greater Manchester will be greatly improved and that we will see patients’ reliance on their reliever medication reduced due to better asthma management. This in turn could reduce asthma flare-ups and avoidable hospital admissions. We believe that the STARRS-GM project will deliver a sustainable legacy of care to ensure improved asthma outcomes for Greater Manchester in the future.”»

Article written by Cora Lydon.



Digital Health